Globe Life (NYSE: GL) CEO reports option exercise and share sales

Rhea-AI Filing Summary

Globe Life Inc. reported insider stock transactions by Co-Chairman, CEO and Director Frank M. Svoboda on December 16, 2025. He exercised an employee stock option to acquire 12,500 shares of common stock at an exercise price of $82.56 per share, then sold portions of those shares on the same day.

The reported sales totaled 6,579 shares at a price shown as $140.2742 per share, with actual sale prices ranging from $139.65 to $140.64, and an additional 2,800 shares at $140.7887 per share, with prices ranging from $140.65 to $141.03. After these transactions, he directly owned 35,868 Globe Life common shares, plus 134,898 shares held through a family trust and 1,947.384 shares through a 401(k) plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SVOBODA FRANK M

(Last) (First) (Middle)

GLOBE LIFE INC.

3700 SOUTH STONEBRIDGE DRIVE

(Street)

MCKINNEY TX 75070

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GLOBE LIFE INC. [ GL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/16/2025		M		12,500	A	$82.56	45,247	D
Common Stock	12/16/2025		S		6,579	D	$140.2742(1)(2)	38,668	D
Common Stock	12/16/2025		S		2,800	D	$140.7887(2)(3)	35,868	D
Common Stock								134,898	I	Family Trust
Common Stock								1,947.384	I	401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$82.56	12/16/2025		M			12,500	02/28/2022	02/28/2026	Common Stock	12,500	$0	12,500	D

Explanation of Responses:

1. Sales at prices ranging from $139.65 per share to $140.64 per share.

2. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

3. Sales at prices ranging from $140.65 per share to $141.03 per share.

	Frank M. Svoboda, By: /s/ Chris T. Moore, Attorney-in-fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Globe Life (GL) disclose in this filing?

The company disclosed that Frank M. Svoboda, Co-Chairman, CEO and Director of Globe Life Inc., exercised stock options and sold shares of common stock on December 16, 2025.

How many Globe Life (GL) shares did Frank M. Svoboda acquire through options?

He exercised an employee stock option to acquire 12,500 shares of Globe Life common stock at an exercise price of $82.56 per share.

How many Globe Life (GL) shares did the CEO sell and at what prices?

He reported selling 6,579 shares at a price shown as $140.2742 per share, with sale prices ranging from $139.65 to $140.64, and another 2,800 shares at $140.7887 per share, with prices ranging from $140.65 to $141.03.

What is Frank M. Svobodas direct ownership in Globe Life (GL) after these transactions?

Following the reported transactions, he directly owned 35,868 shares of Globe Life common stock.

What indirect Globe Life (GL) holdings does the CEO report?

He reported indirect ownership of 134,898 shares of Globe Life common stock through a family trust and 1,947.384 shares through a 401(k) plan.

What derivative security was involved in the Globe Life (GL) insider transaction?

The transaction involved an employee stock option (right to buy) covering 12,500 shares of Globe Life common stock with a $82.56 exercise price and an expiration date of February 28, 2026.